Vinorelbine in Treating Patients With Metastatic Prostate Cancer
Status:
Completed
Trial end date:
1999-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of vinorelbine in treating patients with
metastatic prostate cancer that has not responded to hormone therapy.